El medicamento innovador para vencer la adicción: ¿Ozempic?news2024-11-06T10:40:06+00:00November 6th, 2024|The New York Times|
What Drugmakers Did Not Tell Volunteers in Alzheimer’s Trialsnews2024-10-23T14:19:56+00:00October 23rd, 2024|The New York Times|
Sammy Basso, Advocate for Progeria Research, Is Dead at 28news2024-10-20T16:39:25+00:00October 20th, 2024|The New York Times|
Why We May Soon Use Ozempic to Treat Addictionnews2024-10-18T12:20:09+00:00October 18th, 2024|The New York Times|
Officials Cast Doubt on a Dementia Drug, but Human Trials Continuenews2024-10-02T19:41:40+00:00October 2nd, 2024|The New York Times|
F.D.A. Approves a New Antipsychotic Drugnews2024-09-27T14:36:45+00:00September 27th, 2024|The New York Times|
Qué es la rapamicina y por qué se piensa que sirve para mantenerse jovennews2024-09-24T21:30:27+00:00September 24th, 2024|The New York Times|
Rapamycin and Anti-Aging: What to Knownews2024-09-24T15:26:30+00:00September 24th, 2024|The New York Times|
El ‘médico rural’ que transformó nuestra manera de ver la demencianews2024-09-14T09:03:22+00:00September 14th, 2024|The New York Times|
Francisco Lopera, the ‘Country Doctor’ Who Upended Our Understanding of Dementianews2024-09-11T14:07:34+00:00September 11th, 2024|The New York Times|
